Zichao Yang

No. 2004 Hongli Road
Shenzhen, 518028, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy.

Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy.

Journal: Journal of medicinal chemistry

Published: March 08, 2026

Photocatalytic CO2 Reduction over Cotton-like Blue C/TiO2 Nanotubes: Enhanced Performance via Structural Engineering.

Photocatalytic CO2 Reduction over Cotton-like Blue C/TiO2 Nanotubes: Enhanced Performance via Structural Engineering.

Journal: Nanomaterials (Basel, Switzerland)

Published: November 28, 2025

Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors.

Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors.

Journal: Bioorganic chemistry

Published: September 01, 2025

PXR activation ameliorates hyperuricemic nephropathy via NRF2 signaling.

PXR activation ameliorates hyperuricemic nephropathy via NRF2 signaling.

Journal: Pharmacological research

Published: June 28, 2025

Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment.

Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment.

Journal: Journal of medicinal chemistry

Published: June 16, 2025

Discovery of novel 3-Benzyloxyaminopyridines as orally available and intracranially active selective ROS1 inhibitors for combating the resistant ROS1G2032R mutation.

Discovery of novel 3-Benzyloxyaminopyridines as orally available and intracranially active selective ROS1 inhibitors for combating the resistant ROS1G2032R mutation.

Journal: European journal of medicinal chemistry

Published: June 04, 2025

Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8+ Effector T‑Cell Function for Synergistic Cancer Immunotherapy.

Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8+ Effector T‑Cell Function for Synergistic Cancer Immunotherapy.

Journal: ACS central science

Published: May 06, 2025

Discovery of novel rigid STING PROTAC degraders as potential therapeutics for acute kidney injury.

Discovery of novel rigid STING PROTAC degraders as potential therapeutics for acute kidney injury.

Journal: European journal of medicinal chemistry

Published: February 10, 2025

Targeted protein degradation with small molecules for cancer immunotherapy.

Targeted protein degradation with small molecules for cancer immunotherapy.

Journal: Asian journal of pharmaceutical sciences

Published: October 28, 2024

Influence of Copper Valence in CuOx/TiO2 Catalysts on the Selectivity of Carbon Dioxide Photocatalytic Reduction Products.

Influence of Copper Valence in CuOx/TiO2 Catalysts on the Selectivity of Carbon Dioxide Photocatalytic Reduction Products.

Journal: Nanomaterials (Basel, Switzerland)

Published: October 09, 2024

Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.

Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.

Journal: Journal of medicinal chemistry

Published: July 20, 2024

Corrigendum to "Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity" [Bioorgan. Chem. 117 (2021) 105447].

Corrigendum to "Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity" [Bioorgan. Chem. 117 (2021) 105447].

Journal: Bioorganic chemistry

Published: July 10, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026